Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 2270   Home Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes
Omar Sharif Usmani,Federico Lavorini,Jonathan Marshall,William Christopher Nigel Dunlop,Louise Heron,Emily Farrington,Richard Dekhuijzen
Respiratory Research.2018;19(1)
[DOI]
2Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India
Aloke Ghoshal,Pradyut Waghray,George Dsouza,Mahip Saluja,Mayank Agarwal,Ashish Goyal,Sneha Limaye,Akash Balki,Sudhir Bhatnagar,Manish Jain,Sharad Tikkiwal,Abhijit Vaidya,Meena Lopez,Rashmi Hegde,Jaideep Gogtay
Pulmonary Pharmacology & Therapeutics.2020;60(1)101869
[DOI]
3Single Inhaler LABA/LAMA for COPD
Mario Malerba,Valentina Foci,Filippo Patrucco,Patrizia Pochetti,Matteo Nardin,Corrado Pelaia,Alessandro Radaeli
Frontiers in Pharmacology.2019;10(1)101869
[DOI]
4Patients’ usability of seven most used dry-powder inhalers in COPD
Roberto W. Dal Negro,Paola Turco,Massimiliano Povero
Multidisciplinary Respiratory Medicine.2019;14(1)101869
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal